Copyright
©The Author(s) 2020.
World J Gastroenterol. Mar 7, 2020; 26(9): 918-932
Published online Mar 7, 2020. doi: 10.3748/wjg.v26.i9.918
Published online Mar 7, 2020. doi: 10.3748/wjg.v26.i9.918
Figure 2 TNBS treatment increased the levels of colon L-Kyn in absence of KMO.
KP metabolite levels in the colon of the indicated mice were measured using HPLC. The data are represented as mean ± SE from at least four independent experiments: aP < 0.05 vs Vehicle or TNBS-treated KMO+/+ mice group; bP < 0.01 vs Vehicle or TNBS-treated KMO+/+ mice group; cP < 0.05 vs KMO−/− Vehicle group; and dP < 0.01 vs Vehicle group. KMO: Kynurenine 3-monooxygenase; TNBS: Trinitrobenzene sulfonic acid.
- Citation: Tashita C, Hoshi M, Hirata A, Nakamoto K, Ando T, Hattori T, Yamamoto Y, Tezuka H, Tomita H, Hara A, Saito K. Kynurenine plays an immunosuppressive role in 2,4,6-trinitrobenzene sulfate-induced colitis in mice. World J Gastroenterol 2020; 26(9): 918-932
- URL: https://www.wjgnet.com/1007-9327/full/v26/i9/918.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i9.918